In cancer cells - which often deregulate p53, PRL3 downregulates p53, which can lead to increased cell proliferation and clonogenicity 133, increased G1-S cell cycle progression 61, as well as inhibition of apoptosis 89. The gene discussed is TP53; the disease is cancer.